Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chief Financial Officer

General Counsel

Chief Medical Officer

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones EnergÃƒÂ©ticas, Medioambientales y TecnolÃƒÂ³gicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developin...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-22	Premium	sold	Premium	Premium	Premium	See Remarks
2024-04-15	Premium	acquired	Premium	Premium	Premium	-
2024-04-15	Premium	sold	Premium	Premium	Premium	-
2024-04-12	Premium	acquired	Premium	Premium	Premium	-
2024-04-12	Premium	sold	Premium	Premium	Premium	-
2024-04-08	Premium	sold	Premium	Premium	Premium	See Remarks
2024-04-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-21	Premium	sold	Premium	Premium	Premium	-
2024-03-21	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-29	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-29	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-29	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-16	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-16	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-16	Premium	acquired	Premium	Premium	Premium	CEO
2024-02-16	Premium	sold	Premium	Premium	Premium	CEO
2024-02-16	Premium	acquired	Premium	Premium	Premium	General Counsel
2024-02-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-16	Premium	sold	Premium	Premium	Premium	See Remarks
2024-02-16	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-14	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-14	Premium	sold	Premium	Premium	Premium	General Counsel
2024-02-14	Premium	sold	Premium	Premium	Premium	CEO
2024-02-14	Premium	acquired	Premium	Premium	Premium	See Remarks

RCKT - Rocket Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for RCKT